MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$22,298,702
Equity dividend to
investor
$14,338,993
Net loss
-$7,959,709
(73.49%↑ Y/Y)
Gain on
extinguishment of liability
$5,461,046
Revenues
$54,232
(-97.89%↓ Y/Y)
Change in fair value of
contingent liability
-$1,055,826
Other income, net
$68,376
(-21.40%↓ Y/Y)
Loss from operations
-$13,162,510
(55.35%↑ Y/Y)
Net revenues
$10,846
(-98.87%↓ Y/Y)
Interest expense
$845,051
(33.89%↑ Y/Y)
Cost of revenues
$43,386
(-97.30%↓ Y/Y)
Change in fair value of
investment
-$273,422
Loss on sale of put
shares
-$263,974
Total operating
expenses
$13,173,356
(-56.72%↓ Y/Y)
Legal expenses
(recoveries), net
-$1,470,809
General and
administrative
$7,701,281
(12.60%↑ Y/Y)
Research and development
$5,442,884
(-14.81%↓ Y/Y)
Impairment of long-lived
asset
$1,500,000
Back
Back
Income Statement
source: myfinsight.com
HCW Biologics Inc. (HCWB)
HCW Biologics Inc. (HCWB)